A review of β2-glycoprotein-i antibody testing results from a peer-driven murtilaboratory duality assurance program

American Journal of Clinical Pathology

Volumn 127, Issue 3, 2007, Pages 441-448

  Favaloro, Emmanuel J ^a   Wong, Richard C W ^b   Jovanovich, Susan ^c   Roberts Thomson, Peter ^c  

^a WESTMEAD HOSPITAL   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Anti 2 glycoprotein 1 antibody; Anticardiolipin antibody; Antiphospholipid antibody; Antiphospholipid syndrome; Assays; Laboratory assessment; Quality assurance; Standardization

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; AUTOANTIBODY;

BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IMMUNOASSAY; LABORATORY TEST; MEDICAL INFORMATION SYSTEM; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; STANDARDIZATION; ADULT; AGED; ARTICLE; BLOOD; DIAGNOSIS, MEASUREMENT AND ANALYSIS; EVALUATION; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; REFERENCE VALUE; REPRODUCIBILITY; STANDARD;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; QUALITY CONTROL; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 34147204285     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/L78KJ01CHQM4MK37     Document Type: Review

References (33)

1. Harris EN. Antiphospholipid antibodies. Br J Haematol. 1990;70:1-9.
2. Field SL, Brighton TA, McNeil HP, et al. Recent insights into antiphospholipid antibody-mediated thrombosis. Baillieres Best Pract Res Clin Haematol. 1999;12:407-422.
3. Merrill JT. Which antiphospholipid antibody tests are most useful? Rheum Dis Clin North Am. 2001;27:525-549.
4. Galli M, Finazzi G, Barbui T. Antiphospholipid antibodies: predictive value of laboratory tests. Thromb Haemost. 1997;77:75-78.
5. Galli M, Luciani D, Bettolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827-1832.
6. Galli M, Luciani D, Bettolini G, et al. Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003;102:2717-2723.
7. Galli M, Barbui T. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Semin Thromb Haemost. 2005;31:17-24.
8. Helbert M, Bodger S, Cavenagh J, et al. Optimising testing for phospholipid antibodies. J Clin Pathol. 2001;54:693-698.
9. Marai I, Gilburd B, Blank M, et al. Anti-cardiolipin and anti-beta-2-glycoprotein I antibody assays as screening for antiphospholipid syndrome. Hum Antibodies. 2003;12:57-62.
10. Audrain MAP, Colonna F, Morio F, et al. Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1. Rheumatology (Oxford). 2004;43:181-185.
11. Bertolaccini ML, Gomez S, Pareja JF, et al. Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis. 2005;64:1639-1643.
12. RCPA Quality Assurance Programs Immunology QAP home page. Available at http://www.rcpaqap.com.au/immunology/. Accessed July 13, 2006.
13. Favaloro EJ, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology. 1999;31:142-147.
14. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol. 2002;118:548-557.
15. Favaloro EJ, Wong RC, Silvestrini R, et al. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing. Semin Thromb Hemost. 2005;31:73-84.
16. Harris EN, Gharavi AE, Patel SP, et al. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987;68:215-222.
17. Tomar RH on behalf of the Diagnostic Resource Committee. Antiphospholipid Antibody Survey Set ACL. US CAP Survey. Northfield, IL: College of American Pathologists; 1999.
18. Reber G, Schousboe I, Tincani A, et al. Inter-laboratory variability of anti-beta2-glycoprotein I measurement: a collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost. 2002;88:66-73.
19. Reber G, Tincani A, Sanmarco M, et al, for the European Forum on Antiphospholipid Antibodies Standardization Group. Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays. Thromb Haemost. 2005;94:665-672.
20. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42:1309-1311.
21. Moons KGM, Grobbee DE. When should we remain blind and when should our eyes remain open in diagnostic studies? J Clin Epidemiol. 2002;55:633-636.
22. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299:926-930.
23. Harris EN, Gharavi AEM, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;2:1211-1214.
24. Harris EN, Chan JKH, Asherson RA, et al. Thrombosis, recurrent fetal loss, thrombocytopenia: predictive value of IgG anticardiolipin antibodies. Arch Intern Med. 1986;146:2153-2156.
25. McNeil HP, Krilis SA. Antiphospholipid antibodies. Aust N Z J Med. 1991;21:463-475.
26. Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations: a cooperative project of the European Antiphospholipid Forum. Thromb Haemost. 2001;86:575-583.
27. Wong RCW, Wilson RJ, Pollock W, et al. Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external quality assurance program. Pathology. 2004;36:174-181.
28. Harris EN, Pierangeli SS. Revisiting the anticardiolipin test and its standardization. Lupus. 2002;11:269-275.
29. Wong RCW, Gillis D, Adelstein S, et al. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays. Pathology. 2004;36:182-192.
30. Wong R, Adelstein S, Gillis D, et al. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing. Semin Thromb Hemost. 2005;31:39-48.
31. Wong RCW, Gillis D, Adelstein S, et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology. 2004;36:63-68.
32. Ichikawa K, Tsutsumi A, Atsumi T, et al. A chimeric antibody with the human γ1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum. 1999;42:2461-2470.
33. Tsutsumi A, Ichikawa K, Matsuura E, et al. Heterogeneous behavior of anti-beta2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with beta2-glycoprotein I. J Rheumatol. 2000;27:391-396.